MARKET NEWS

Emerald Health Pharmaceuticals Begins Enrollment in Phase 2a Study
Daré Bioscience Announces Initiation of Phase 1 Clinical Trial of  Novel Intravaginal Ring Designed to Deliver Non-oral, Bio-identical Hormone Therapy 
LGM Pharma Acquires Pharmaceutical Development & Manufacturing Unit of Nexgen Pharma
Oculis Announces Successful End-of-Phase 2 Meeting With the FDA
Sterling Signs Deal to Produce Potential COVID-19 Drug Candidate for Moleculin
DalCor Announces dal-GenE Trial Continues With Final Data Expected in the First Half of 2021

  FEATURED EDITORIAL

  COMPANY PROFILE

Lyophilization Technology, Inc. (LTI) is a Contract Development & Manufacturing Organization (CDMO) focused on all aspects of lyophilization for preparation of health care products. Clients leverage on our abilities for bringing new products to the clinic and implementing improvements for current products. Capitalize on over 25 years of excellence and our unparalleled capabilities in product development, process engineering, clinical manufacturing, and technical support. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Editas Medicine Enters Into Strategic Partnership With Catalent to Support Gene-Editing Medicine Pipeline

Editas Medicine Enters Into Strategic Partnership With Catalent to Support Gene-Editing Medicine Pipeline

Editas Medicine, Inc. and Catalent recently announced they have entered into a strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical supply of….

Arrowhead Pharmaceuticals Earns -Million Milestone Payment From Amgen

Arrowhead Pharmaceuticals Earns $20-Million Milestone Payment From Amgen

Arrowhead Pharmaceuticals Inc. recently announced it has earned a $20-million milestone payment from Amgen following the administration of the first dose of….

PMI BioPharma Solutions Rebrands to August Bioservices, Closes Investment From Oak HC/FT to Accelerate Growth

PMI BioPharma Solutions Rebrands to August Bioservices, Closes Investment From Oak HC/FT to Accelerate Growth

PMI BioPharma Solutions recently announced new funding from Oak HC/FT to expand its capabilities to become a specialized, one-stop-shop CDMO for clinical and commercial injectable therapies…..

NGM Bio Announces Initiation of Phase 2 CATALINA Study

NGM Bio Announces Initiation of Phase 2 CATALINA Study

NGM Biopharmaceuticals, Inc. recently announced it has initiated the Phase 2 CATALINA study, a multicenter, randomized, double-masked, sham-controlled clinical trial, to evaluate the safety and efficacy of….

Cost of Disrupted Clinical Research Due to COVID-19 Equates to + Billion & Potential Study Delays

Cost of Disrupted Clinical Research Due to COVID-19 Equates to $10+ Billion & Potential Study Delays

What if you developed a potential cure for COVID-19, but couldn’t test the drug because of COVID-19? Thousands of researchers worldwide are facing this dilemma, as clinical studies are interrupted, altered, postponed – or even cancelled…

Wearable Drug Delivery Provider Sorrel Medical Partners With Leading Global Pharmaceutical Manufacturer

Wearable Drug Delivery Provider Sorrel Medical Partners With Leading Global Pharmaceutical Manufacturer

Sorrel Medical recently announced it has entered into a strategic partnership with one of the world’s leading pharmaceutical companies to advance the development and introduction of next-generation wearable drug delivery solutions….

Frontage Laboratories 2020 Podcast Series

Frontage Laboratories 2020 Podcast Series

Welcome to Frontage Laboratories 2020 Podcast Series. Listen to our full suite of podcasts of engaging topics from our top scientific experts.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

August 12 – Analytical Testing
August 19 – ODT/Fast Dissolve